Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.62 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.41 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.38 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.35 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.35 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.35 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.35 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23926938 | 0.80 | ALOX15 (0.33) | ALOX15 | |
| SCHEMBL3975418 | 0.79 | ALOX15 (1.00) | ALOX15SIGMAR1ACE2PRMT3CARM1 | |
| SCHEMBL242967 | 0.79 | — | — | |
| SCHEMBL179843 | 0.79 | ALOX15 (1.00) | ALOX15SIGMAR1ACE2PRMT3CARM1 | |
| SCHEMBL9325445 | 0.76 | ALOX15 (0.62) | ALOX15SIGMAR1ACE2ALDH1A1 | |
| SCHEMBL7056594 | 0.76 | ALOX15 (0.62) | ALOX15SIGMAR1ACE2PRMT3CARM1 | |
| SCHEMBL10662555 | 0.76 | DRD2 (0.44) | SIGMAR1 | |
| SCHEMBL11541738 | 0.76 | ALOX15 (0.93) | ALOX15SIGMAR1ACE2PRMT3CARM1 | |
| SCHEMBL11501587 | 0.76 | ALOX15 (0.93) | ALOX15SIGMAR1ACE2PRMT3CARM1 | |
| SCHEMBL10657638 | 0.73 | GNAI3 (0.44) | SIGMAR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3901096-B1 | CERIUM OXIDE NANOPARTICLES, METHOD FOR ANALYZING NUCLEIC ACID, METHOD FOR ANALYZING POLYPEPTIDE, METHOD FOR MANUFACTURING CERIUM OXIDE NANOPARTICLES, OXIDIZING AGENT, ANTIOXIDANT, ANTIFUNGAL AGENT, AND ANTIVIRAL AGENT | TORAY INDUSTRIES (JP) | 2025-03-05 | — | — | EP | disclosed |
| US-20250000097-A1 | CERIUM OXIDE NANOPARTICLE, DISPERSION SOLUTION, ANTIVIRAL AGENT, ANTIBACTERIAL AGENT, RESIN COMPOSITION, RESIN PRODUCT, FIBER MATERIAL, FIBER PRODUCT, AND METHOD OF PRODUCING CERIUM OXIDE NANOPARTICLE | TORAY INDUSTRIES, INC. (JP) | 2025-01-02 | — | — | US | disclosed |
| CN-113194932-B | Cerium oxide nanoparticle, method for decomposing nucleic acid, method for decomposing polypeptide, method for producing cerium oxide nanoparticle, oxidizing agent, antioxidant, antifungal agent, and antiviral agent | 东丽株式会社 | 2024-06-28 | — | — | CN | disclosed |
| CN-118019715-A | Cerium oxide nanoparticle, dispersion, antiviral agent, antibacterial agent, resin composition, resin article, fiber material, fiber article, and method for producing cerium oxide nanoparticle | 东丽株式会社 | 2024-05-10 | — | — | CN | disclosed |
| US-11937598-B2 | Cerium oxide nanoparticle, decomposition method of nucleic acid, decomposition method of polypeptide, method of producing cerium oxide nanoparticle, oxidizing agent, antioxidant, antifungal agent, and anti-virus agent | TORAY INDUSTRIES, INC. (JP) | 2024-03-26 | — | — | US | disclosed |
| WO-2023054456-A1 | CERIUM OXIDE NANOPARTICLES, DISPERSION, ANTIVIRAL AGENT, ANTIMICROBIAL AGENT, RESIN COMPOSITION, RESIN PRODUCT, FIBER MATERIAL, FIBER PRODUCT, AND METHOD FOR PRODUCING CERIUM OXIDE NANOPARTICLES | 東レ株式会社 | 2023-04-06 | — | — | WO | disclosed |
| US-20220030857-A1 | CERIUM OXIDE NANOPARTICLE, DECOMPOSITION METHOD OF NUCLEIC ACID, DECOMPOSITION METHOD OF POLYPEPTIDE, METHOD OF PRODUCING CERIUM OXIDE NANOPARTICLE, OXIDIZING AGENT, ANTIOXIDANT, ANTIFUNGAL AGENT, AND ANTI-VIRUS AGENT | TORAY INDUSTRIES, INC. (JP) | 2022-02-03 | — | — | US | disclosed |
| EP-3901096-A1 | CERIUM OXIDE NANOPARTICLES, METHOD FOR ANALYZING NUCLEIC ACID, METHOD FOR ANALYZING POLYPEPTIDE, METHOD FOR MANUFACTURING CERIUM OXIDE NANOPARTICLES, OXIDIZING AGENT, ANTIOXIDANT, ANTIFUNGAL AGENT, AND ANTIVIRAL AGENT | Toray Industries, Inc. (JP) | 2021-10-27 | — | — | EP | disclosed |
| CN-113194932-A | Cerium oxide nanoparticles, method for decomposing nucleic acid, method for decomposing polypeptide, method for producing cerium oxide nanoparticles, oxidizing agent, antioxidant, antifungal agent, and antiviral agent | 东丽株式会社 | 2021-07-30 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250000097-A1 | CERIUM OXIDE NANOPARTICLE, DISPERSION SOLUTION, ANTIVIRAL AGENT, ANTIBACTERIAL AGENT, RESIN COMPOSITION, RESIN PRODUCT, FIBER MATERIAL, FIBER PRODUCT, AND METHOD OF PRODUCING CERIUM OXIDE NANOPARTICLE | CAD, ERO1A, GART | ALOX15 2411/4885SIGMAR1 2573/4885ACE2 1796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.